Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements
Michael Miller, Lâle Tokgözoğlu, Klaus G. Parhofer, et al.
Expert Review of Cardiovascular Therapy (2022) Vol. 20, Iss. 8, pp. 609-625
Open Access | Times Cited: 16

Showing 16 citing articles:

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
Anita Ioana Vișan, Irina Neguț
Life (2024) Vol. 14, Iss. 2, pp. 233-233
Open Access | Times Cited: 84
The Interplay Between Immunity, Inflammation and Endothelial Dysfunction
Ying Jie Chee, Rinkoo Dalan, Christine Cheung
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1708-1708
Open Access | Times Cited: 1
Lipids dysregulation in diseases: core concepts, targets and treatment strategies
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Transform Drug Discovery and Development With Generative Artificial Intelligence
Antonio Lavecchia
(2025), pp. 489-537
Closed Access
Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women
Wendy L. Hall
Proceedings of The Nutrition Society (2024), pp. 1-12
Open Access | Times Cited: 3
Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
Pilar Irún, Patricia Carrera‐Lasfuentes, Marta Sánchez‐Luengo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16143-16143
Open Access | Times Cited: 5
Therapeutic Strategies to Prevent Recurrent Stroke
Miguel Camafort, Eugene Yang, Carlos I. Ponte, et al.
Updates in hypertension and cardiovascular protection (2024), pp. 229-243
Closed Access | Times Cited: 1
Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
Krishnaswami Vijayaraghavan, Seth J. Baum, Nihar R. Desai, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 1
Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention
Vera Bittner
Circulation (2024) Vol. 150, Iss. 6, pp. 435-438
Closed Access | Times Cited: 1
Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
Peter P. Tóth, Jean Ferrières, M Waters, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function
Francine K. Welty, Ralph Daher, Mahdi Garelnabi
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 44, Iss. 1, pp. 89-107
Open Access | Times Cited: 2
Pleiotropic beneficial cardiometabolic actions of a high‐purity eicosapentaenoic acid product in high cardiovascular risk individuals
Charalampos I. Liakos, Leonidas Lanaras, Magdalini Bristianou, et al.
Lipids (2024) Vol. 59, Iss. 3, pp. 67-74
Open Access
Advances in the pharmacological management of hyperlipidemia through the use of combination therapies
Anthony S. Wierzbicki
Expert Opinion on Pharmacotherapy (2024), pp. 1-9
Closed Access
Impact of eicosapentaenoic acid on cardiovascular outcomes after acute coronary syndrome: a systematic review and meta-analysis of randomized clinical trials
Parisa Fallahtafti, Sepehr Nayebirad, Elaheh Karimi, et al.
Cardiology Plus (2024) Vol. 9, Iss. 4, pp. 260-268
Open Access
Re: ‘Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: a meta-analysis’
Sephy Philip
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 2, pp. 322-322
Open Access | Times Cited: 1
A Time Course Study of Lipid Mediators after Consumption of SPM-Enriched Marine Oil in Healthy Subjects
Pilar Irún, Patricia Carrera‐Lasfuentes, Marta Sánchez‐Luengo, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top